haloperidol decanoate has been researched along with Amphetamine-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gedzior, JS; Matthew, BJ | 1 |
| Kubakawa, T; Niimura, H | 1 |
1 review(s) available for haloperidol decanoate and Amphetamine-Related Disorders
| Article | Year |
|---|---|
[Psychiatric care for patients with addiction of amphetamine, CNS stimulant].
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Crime; Female; Haloperidol; Humans; Japan; Male; Middle Aged; Substance Abuse Detection | 2009 |
1 other study(ies) available for haloperidol decanoate and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate.
Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal | 2015 |